Scientists and doctors in recent decades have made vast leaps in the treatment of cardiac problems - particularly with the development in recent years of so-called "cardiac patches," swaths of engineered heart tissue that can replace heart muscle damaged during a heart attack.

Thanks to the work of Charles Lieber and others, the next leap may be in sight.

The Mark Hyman, Jr. Professor of Chemistry and Chair of the Department of Chemistry and Chemical Biology, Lieber, postdoctoral fellow Xiaochuan Dai and other co-authors of a study that describes the construction of nanoscale electronic scaffolds that can be seeded with cardiac cells to produce a "bionic" cardiac patch. The study is described in a June 27 paper published in Nature Nanotechnology.

Scientists at Emory Vaccine Center, in collaboration with investigators from Thailand, have found that people infected with dengue virus develop antibodies that cross-react with Zika virus.

Some of these antibodies have the potential to neutralize Zika virus - possibly providing immune protection. At the same time, in laboratory experiments, antibodies against dengue could enhance Zika virus infection of human cells.

The results are scheduled for publication on Monday, June 27 in PNAS.

As oil producers struggle to adapt to lower prices, getting as much oil as possible out of every well has become even more important, despite concerns from nearby residents that some chemicals used to boost production may pollute underground water resources.

Researchers from the University of Houston have reported the discovery of a nanotechnology-based solution that could address both issues - achieving 15 percent tertiary oil recovery at low cost, without the large volume of chemicals used in most commercial fluids.

(Vienna, 23 June 2016) Four new papers, co-published by an international consortium of biomedical researchers, mark the feasibility of epigenetic analysis for clinical diagnostics and precision medicine. Epigenetic analysis addresses key limitations of genetic testing, helping to ensure that patients are accurately diagnosed and treated with the right drug at the right time.

Epigenetic changes occur in all cancers, and in various other diseases. Measuring these changes provides unprecedented insights into the disease mechanisms at work in individual patients, which is important for better diagnosis and patient-specific treatment decisions.

A team of scientists has uncovered the global, evolving, and historic make-up of Plasmodium vivax, one of the five species of malaria that infect humans. The research, which links the spread of the parasite back to colonial seafaring, among other phenomena, underscores the challenges health experts face in controlling the parasite.

"Plasmodium vivax is going to be the last malaria parasite standing," observes Jane Carlton, a professor in New York University's Department of Biology, who led the study. "Our findings show it is evolving in response to anti-malarial drugs and adapting to regional differences, indicating a wide range of approaches will likely be necessary to eliminate it globally."

Washington, DC-- It turns out that forests in the Andean and western Amazonian regions of South America break long-understood rules about how ecosystems are put together, according to new research led by Carnegie's Greg Asner and published in the Proceedings of the National Academy of Sciences. Their findings could help scientists understand how tropical forests will respond to global climate change.

One of forest ecology's fundamental undertakings has long focused on how tree growth is influenced by a host of environmental factors ranging from soils and elevation to hydrology and climate. These factors create an economy of resources that the trees must exploit through different strategies, some of which are optimized for quick growth while others favor slow growth.